TFRC and cancer: Overall, this suggests that the efficacy of transferrin receptor targeting may be improved in two ways: (1) by confirming the overexpression in the tumors of individual patients by molecular imaging, and (2) by modulating iron availability to increase expression of TfR by cancer cells.